For in-vitro research only · Not for human use · 18+

New prices. Permanently 30% lower.Already marked down from original prices · No code needed
Back to catalogue
Tirzepatide 15mg research peptide vial — Aussie Peptides
Incretin-receptor agonists

Product illustration — not a lot photograph or test evidence.

Tirzepatide 15 mgResearch peptide

$153.30

per vial

$219.00

In stock

Price is per single vial.

1

Batch documents: Not published online

Laboratory research listing — not offered for human or veterinary use. 18+. Full notice

Details

Research overview

Tirzepatide (also catalogued as LY3298176) is classified as: dual GIP / GLP-1 receptor agonist peptide. Aussie Peptides lists it as a research reference material in a 15mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Reference data

Tirzepatide molecular information

Also known as
LY3298176
Classification
Dual GIP / GLP-1 receptor agonist peptide
Molecular formula
C225H348N48O68
Average molecular mass
4813.5 g/mol
CAS number
2023788-19-2
Look up Tirzepatide on PubChem

Batch documentation for Tirzepatide 15mg

No batch report is published online for this product yet. When one is, it will be matched to its lot number on the verify page. Check a lot number · How to read a batch report

Aussie Peptides brand mark

Aussie Peptides · specification

Tirzepatide 15 mg

Labelled amount
15mg
SKU
TIRZEPATIDE-15MG
Batch report
Not published online
Handling data
Supplier SDS and your institutional SOP
Category
Incretin-receptor agonists

Batch results apply only to the lot they were measured on. Where a report has been published for your lot, it can be looked up on the verify page.

Check a lot →Reading a batch report →

Batch documentation

Not published online for this product yet.

Look up a lot number · About batch reports

Laboratory handling

Handling & documentation

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for Tirzepatide 15 mg. Base storage, reconstitution and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.

  • Record the lot number and expiry printed on the label when the item is received.
  • Check the verify page for a published batch report matching that lot.
  • Wear appropriate PPE and dispose of vials, sharps and unused material under your institution's waste procedures.

Ask by email if you need the supplier SDS for this item. Contact

No dosage advice

Aussie Peptides does not publish, supply or advise on human or veterinary dosing, administration or therapeutic use of any product, and nothing on this page should be read as such or as medical advice.

Products are listed for laboratory research and are not offered for human or animal consumption. A “research use only” label does not by itself determine regulatory status.

Research-use notice
Shipping

Shipping within Australia. Rates are set out in the shipping policy and match checkout; courier delivery times are estimates, not guarantees.

Tirzepatide research guide

Molecular identity, GIP and GLP-1 receptor pharmacology, and the limits of comparing published assay results. In-vitro research only.

Other strengths and blends in stock

Questions

Tirzepatide 15 mg — frequently asked

What is Tirzepatide?+

Tirzepatide (also catalogued as LY3298176) is classified as: dual GIP / GLP-1 receptor agonist peptide. Aussie Peptides lists it as a research reference material in a 15mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Is a batch report published for Tirzepatide 15mg?+

Not at the moment. No batch report is published online for this product. Results belong to a specific lot; if a report is published later it will be matched to its lot number on the verify page, and you can ask by email whether one is available.

Check a lot numberHow to read a batch report

Where do I find storage and handling information for Tirzepatide?+

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for this item. Use the supplier safety data sheet (SDS) and your institution's standard operating procedures, and record the lot number printed on the vial.

What is the intended use of Tirzepatide?+

It is listed for laboratory research and is not offered for human or veterinary use. A “research use only” label does not by itself determine a product's regulatory status in Australia; the TGA explains how it regulates peptide products. Purchasers remain responsible for their own legal and institutional obligations.

Intended use and complianceTGA guidance on peptide products

How much is Tirzepatide 15mg and how is it shipped?+

The listed price is $153.30. The catalogue currently lists it as in stock. Current shipping rates and delivery estimates are set out in the shipping policy. Delivery times are courier estimates, not guarantees.

Shipping policy

Keep exploring

More from Incretin-receptor agonists